FdaApplication
NDA 209884
Identifiers
- fda_app_no: NDA209884
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2019-03-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MAYZENT | SIPONIMOD | EQ 1MG BASE | TABLET;ORAL |
| MAYZENT | SIPONIMOD | EQ 0.25MG BASE | TABLET;ORAL |
| MAYZENT | SIPONIMOD | EQ 2MG BASE | TABLET;ORAL |
3 products